Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults

International Journal of Infectious Diseases

Volumn 12, Issue 6, 2008, Pages

  Bailey, Christina L ^a   Smith, Vanessa ^a   Sands, Michael ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

Hepatitis B; Hepatitis B vaccination; Hepatitis B vaccination guidelines; Hepatitis B vaccine efficacy; HIV

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; TREATMENT RESPONSE; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; GUIDELINE ADHERENCE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNIZATION; IMMUNIZATION SCHEDULE; MALE; MASS SCREENING; MIDDLE AGED; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 54349088210     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.05.1226     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. Achievements in public health: hepatitis B vaccination-United States, 1982-2002. MMWR Morb Mortal Wkly Rep 51 (2002) 549-552
2. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults. MMWR Morb Mortal Wkly Rep 55 RR-16 (2006) 1-31
3. Aberg J.A., Gallant J.E., Anderson J., Oleske J.M., Libman H., Stone V.E., et al. Primary care guidelines for the management of persons with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 39 (2004) 609-629
4. Centers for Disease Control and Prevention. Recommendations of the Immunization Practices Advisory Board (ACIP): inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep 31 (1982) 317-328
5. Tedaldi E.M., Baker R.K., Moorman A.C., Wood K.C., Fuhrer J., McCabe R.E., et al. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis 38 (2004) 1478-1484
6. Wilson C.M., Ellenberg J.H., Sawyer M.K., Belzer M., Crowley-Norwick P.A., Puga A., et al. Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health. J Adolesc Health 29 3 Suppl (2001) 123-129
7. Hess G., Rossol S., Voth R., Cheatam-Speth D., Clemens R., and Meyer zum Buschenfelde K. Active immunization of homosexual men using a recombinant hepatitis B vaccine. J Med Virol 29 (1989) 229-231
8. Rey D., Krantz V., Partisani M., Schmitt M.P., Meyer P., Libbrecht E., et al. Increasing the number of hepatitis B injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine 18 (2000) 1161-1165
9. Gardner P., Pickering L.K., Orenstein W.A., Gershon A.A., and Nichol K.L. Guidelines for quality standards in immunization. Clin Infect Dis 35 (2002) 503-511
10. US Department of Health and Human Services. Healthy people 2010. Understanding and improving health and objectives for improving health. 2nd ed. Vol. 1 (2000), US Government Printing Office, Washington, DC p. 14.3-14.59
11. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP): immunization of infants, children, and adolescents. MMWR Morb Mortal Wkly Rep 54 RR-16 (2005) 1-23
12. Kellerman S.E., Hanson D.L., McNaghten A.D., and Fleming P.L. Prevalence of chronic hepatitis B infection in human immunodeficiency-virus infected subjects. J Infect Dis 188 (2003) 571-577
13. Goldstein S.T., Alter M.J., Williams I.T., Moyer L.A., Judson F.N., Mottram K., et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 185 (2002) 713-719
14. Hollinger F.B. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med 87 3A (1989) 36S-40S
15. Laurence J.C. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. Am J Med 118 10A (2005) 75S-83S
16. Overton E.T., Sungkanuparph S., Powderly W.G., Seyfried W., Groger R.K., and Aberg J.A. Undetectable plasma HIV viral load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis 41 (2005) 1045-1048
17. Gandhi R.T., Wurcel A., Lee H., McGover B., Shopis J., Geary M., et al. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. J Infect Dis 191 (2005) 435-441
18. Collier A.C., Corey L., Murphy V.L., and Handsfield H.H. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 109 (1988) 101-105
19. Wong E.R., Bodsworth N.J., Slade M.A., Mulhall B.P., and Donovan B. Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4 lymphocyte count, and vaccination schedule. Int J STD AIDS 7 (1996) 490-494
20. Thio C.L., Seaberg E.C., Skolasky Jr. R., Phair J., Visscher B., Munoz A., et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360 (2002) 1921-1926
21. Savage R.B., Hussey M.J., and Hurie M.B. A successful approach to immunizing men who have sex with men against hepatitis B. Public Health Nurs 17 (2000) 202-206
22. Winnock M., Neau D., Castera L., Viot J., Lacoste D., Pellegrin J.L., et al. Hepatitis B vaccination in HIV-positive patients: a survey of physicians and patients participating in the Aquitaine cohort. Gastroenterol Clin Biol 30 (2006) 189-195
23. MacKellar D.A., Valleroy L.A., Secura G.M., McFarland W., Shehan D., For W., et al. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health 91 (2001) 965-971
24. Neau D., Winnock M., Jouvencel A., Faure M., Castera L., Legrand E., et al. Occult hepatitis B infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis 40 (2005) 750-753
25. Gandhi R.T., Wurcel A., Lee H., McGovern B., Boczanowski M., Gerwin R., et al. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis 36 (2003) 1602-1605
26. Neau D., Winnock M., Galperine T., Jouvencel A.C., Castera L., Legrand E., et al. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med 5 (2004) 171-173
27. Alhababi F., Sallam T.A., and Tong C.Y. The significance of 'anti-HBc only' in the clinical virology laboratory. J Clin Virol 27 (2003) 162-169
28. Shire N.J., Rouster S.D., Rajicic N., and Sherman K.E. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr 36 (2004) 869-875
29. Ural O., and Findik D. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J Infect 43 (2001) 187-190
30. Lok A.S., Lai C.L., and Wu P.C. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 8 (1988) 766-770
31. Kahn J. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men. Clin Infect Dis 35 (2002) 1382-1387